133 related articles for article (PubMed ID: 23007424)
21. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
22. Virtual tissues in toxicology.
Shah I; Wambaugh J
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):314-28. PubMed ID: 20574905
[TBL] [Abstract][Full Text] [Related]
23. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
24. ACToR--Aggregated Computational Toxicology Resource.
Judson R; Richard A; Dix D; Houck K; Elloumi F; Martin M; Cathey T; Transue TR; Spencer R; Wolf M
Toxicol Appl Pharmacol; 2008 Nov; 233(1):7-13. PubMed ID: 18671997
[TBL] [Abstract][Full Text] [Related]
25. An integrated QSPR-PBPK modelling approach for in vitro-in vivo extrapolation of pharmacokinetics in rats.
Kamgang E; Peyret T; Krishnan K
SAR QSAR Environ Res; 2008; 19(7-8):669-80. PubMed ID: 19061083
[TBL] [Abstract][Full Text] [Related]
26. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
el-Masri HA; Reardon KF; Yang RS
Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
[TBL] [Abstract][Full Text] [Related]
27. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment.
Dixit R; Riviere J; Krishnan K; Andersen ME
J Toxicol Environ Health B Crit Rev; 2003; 6(1):1-40. PubMed ID: 12587252
[TBL] [Abstract][Full Text] [Related]
28. Modeling Pharmacokinetics.
Bois FY; Brochot C
Methods Mol Biol; 2016; 1425():37-62. PubMed ID: 27311461
[TBL] [Abstract][Full Text] [Related]
29. Computational science in drug metabolism and toxicology.
Valerio LG
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
[TBL] [Abstract][Full Text] [Related]
30. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
El-Masri HA
Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
[TBL] [Abstract][Full Text] [Related]
31. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
Poirier A; Funk C; Scherrmann JM; Lavé T
Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
[TBL] [Abstract][Full Text] [Related]
33. Physiologically based pharmacokinetic modeling for nanoparticle toxicity study.
Li M; Reineke J
Methods Mol Biol; 2012; 926():369-82. PubMed ID: 22975976
[TBL] [Abstract][Full Text] [Related]
34. Systems toxicology from genes to organs.
Jack J; Wambaugh J; Shah I
Methods Mol Biol; 2013; 930():375-97. PubMed ID: 23086851
[TBL] [Abstract][Full Text] [Related]
35. Computational toxicology: Physiologically based pharmacokinetic models (PBPK) for lifetime exposure and bioaccumulation of polybrominated diphenyl ethers (PBDEs) in marine mammals.
Weijs L; Covaci A; Yang RS; Das K; Blust R
Environ Pollut; 2012 Apr; 163():134-41. PubMed ID: 22325441
[TBL] [Abstract][Full Text] [Related]
36. Integration of Life-Stage Physiologically Based Pharmacokinetic Models with Adverse Outcome Pathways and Environmental Exposure Models to Screen for Environmental Hazards.
El-Masri H; Kleinstreuer N; Hines RN; Adams L; Tal T; Isaacs K; Wetmore BA; Tan YM
Toxicol Sci; 2016 Jul; 152(1):230-43. PubMed ID: 27208077
[TBL] [Abstract][Full Text] [Related]
37. Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data.
Young JF; Wosilait WD; Luecke RH
J Toxicol Environ Health A; 2001 May; 63(1):19-52. PubMed ID: 11346132
[TBL] [Abstract][Full Text] [Related]
38. Toxicology of chemical mixtures: a challenging quest along empirical sciences.
Groten JP; Heijne WH; Stierum RH; Freidig AP; Feron VJ
Environ Toxicol Pharmacol; 2004 Dec; 18(3):185-92. PubMed ID: 21782748
[TBL] [Abstract][Full Text] [Related]
39. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
Aylward LL; Kirman CR; Blount BC; Hays SM
Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
[TBL] [Abstract][Full Text] [Related]
40. From a theoretical framework of human exposure and dose assessment to computational system implementation: the Modeling ENvironment for TOtal Risk Studies (MENTOR).
Georgopoulos PG; Lioy PJ
J Toxicol Environ Health B Crit Rev; 2006; 9(6):457-83. PubMed ID: 17090483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
